[Updated March 12] Knoxville-based Provectus Pharmaceuticals will net about $5.3 MM after a private placement transaction, the company announced today. The company specializes in oncology and dermatological therapies. The release is here. In a March 12 release, Provectus said it expects to gross about $7.9 million on the transaction.
Tuesday, March 09, 2010
Provectus gets $5.3MM in PE transaction
[Updated March 12] Knoxville-based Provectus Pharmaceuticals will net about $5.3 MM after a private placement transaction, the company announced today. The company specializes in oncology and dermatological therapies. The release is here. In a March 12 release, Provectus said it expects to gross about $7.9 million on the transaction.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment